Tekton Research and Summit Clinical Research Solutions Expand Partnership, Bring MASH Trials to OhioNEW CARLISLE, Ohio, July 08, 2026 (GLOBE NEWSWIRE) -- Tekton Research, a multi-specialty clinical research site organization, is expanding its partnership with Summit Clinical Research Solutions (“Summit”). Under the supervision of Ashok Devatha, MD, Tekton’s New Carlisle, Ohio site will serve as a community-based access point for metabolic dysfunction-associated steatohepatitis (MASH) and metabolic dysfunction-associated steatotic liver disease (MASLD) clinical trials.
Tekton Research Appoints Dr. Amit Vijapura as Central Nervous System Key Opinion LeaderAs CNS capabilities expand, Tekton adds seasoned leadership to accelerate growth and execution
Tekton Research Appoints Dr. Jara McDonald as Executive Medical Director to Support Continued Growth in Cardiometabolic ResearchDouble Board-Certified Obesity, Diabetes & Integrative Medicine Specialist to Lead Medical Strategy, Sponsor Engagement, and Industry Collaboration
